NEW YORK (GenomeWeb) – Response Genetics today after the close of the market reported a 15 percent decrease year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, Response Genetics' total revenues decreased to $4.1 million from $4.8 million in the prior-year period.

Revenue from ResponseDX cancer tests was $3.7 million for the quarter ended Dec. 31, 2014, compared to $3.2 million for the prior-year period, an increase of 16 percent, but revenue from pharmaceutical clients dropped 67 percent to $400,000 in Q4 2014 from $1.6 million in 2013.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.